A Win For Cidara Therapeutics, Inc.
Mon, Jun 23, 2025 at 07:29 PM
Cidara Therapeutics, Inc. (CDTX:NASDAQ) rocketted at $44.95, representing a gain of 113.8%. On Mon, Jun 23, 2025, CDTX:NASDAQ hit a New 2-Week High of $44.95. The stock got featured on our News Catalysts scanner on Mon, Jun 23, 2025 at 06:20 PM in the 'PUBLIC OFFERING' category. From Mon, Jun 09, 2025, the stock recorded 22.22% Up Days and 30.00% Green Days
About Cidara Therapeutics, Inc. (CDTX:NASDAQ)
Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, CloudbreakTM.
Top 10 Gainers:
- Impact BioMedical Inc. (IBO:NYSEMKT), 344.63%
- Highest Performances Holdings Inc. (MAAS:NASDAQ), 267.78%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 113.84%
- Indaptus Therapeutics, Inc. (INDP:NASDAQ), 85.12%
- Geospace Technologies Corporation (GEOS:NASDAQ), 60.14%
- OceanPal Inc. (OP:NASDAQ), 52.78%
- SpartanNash Company (SPTN:NASDAQ), 50.62%
- So-Young International Inc. (SY:NASDAQ), 41.88%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 38.6%
- Energy Focus, Inc. (EFOI:NASDAQ), 35.54%